Erlend Petter Skagseth
Directeur/Membre du Conseil chez COEGIN PHARMA AB
Profil
Erlend Petter Skagseth is currently the Chairman at GeneSeque AS, APIM Therapeutics AS, SeaFarm Solutions AS, Serca Pharmaceuticals AS, Caedo Oncology AS, Mitosis AS, and the Director at Med Storm Innovation AS, Prophylix AS, Coegin Pharma AB, and Prophylix Holding AS.
He previously held positions as the Managing Partner at Sarsia Seed Management AS, Chairman at Blue Limit AS, Director at Christian Michelsen Research AS, Sarsia Innovation AS, Caerus Capital AS, Nykode Therapeutics ASA, and Delante Health AS.
Postes actifs de Erlend Petter Skagseth
| Sociétés | Poste | Début |
|---|---|---|
| COEGIN PHARMA AB | Directeur/Membre du Conseil | 01/09/2020 |
Sarsia Seed Management AS
 Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Directeur Général | 01/03/2016 |
| Mitosis AS | Président | - |
| Caedo Oncology AS | Président | - |
| Prophylix Holding AS | Directeur/Membre du Conseil | - |
Serca Pharmaceuticals AS
 Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Serca Pharmaceuticals AS develops, markets, and sells drug treatment products, medicinal products, and equipment for injuries. The company was founded on October 8, 2018 and is headquartered in Lysaker, Norway. | Président | - |
Med Storm Innovation AS
 Med Storm Innovation AS Medical DistributorsDistribution Services Med Storm Innovation AS develops bio sensor systems. It develops medical software solutions for analyzing skin conductance or emotional sweating for monitoring and detecting stress/pain and awakening on patients. The company was founded by Hanne Storm on December 22, 1998 and is headquartered in Oslo, Norway. | Directeur/Membre du Conseil | - |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Président | 14/01/2014 |
SeaFarm Solutions AS
 SeaFarm Solutions AS Agricultural Commodities/MillingProcess Industries Seafarm Solutions AS designs, produces, and sells goods and services to the fishing industry. It manufactures machines and equipment for the fish farmers. The company was founded by Claus Mikael Søberg and Morten Aga on August 10, 2000 and is headquartered in Vaksdal, Norway. | Président | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Erlend Petter Skagseth
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░ ░░░░░ ░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NYKODE THERAPEUTICS | Health Technology |
| COEGIN PHARMA AB | Health Technology |
| Entreprise privées | 15 |
|---|---|
Sarsia Seed Management AS
Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Finance |
Blue Limit AS
 Blue Limit AS Agricultural Commodities/MillingProcess Industries Blue Limit AS is a holding company that develops, protects, produces, and sells early stage larvae feed for shrimp and mollusks. The firm offers feed for the vulnerable early development phases of fish and shellfish larvae. It is a norwegian aquaculture feed company that launches shrimp larvae feed. The firm is categorized under other research and experimental development on natural sciences and engineering. The company was founded by Anders Aksnes on June 29, 2006 and is headquartered in Bergen, Norway. | Process Industries |
Delante Health AS
 Delante Health AS Food: Specialty/CandyConsumer Non-Durables Delante Health AS specializes in the manufacture of nutritional products. It engages in the production of products with vitamins and minerals. The firm's product platform Lipidfizz is a patented omega-3 drink powder delivered in individual servings. Its technology enables consumption of omega-3 and other polyunsaturated fatty acids in effervescent powders and tablets. The company was founded by Hans Robert Wahren and Bjørn Skjævestad in 2005 and is headquartered in Bekkestua, Norway. | Consumer Non-Durables |
GeneSeque AS
 GeneSeque AS Medical SpecialtiesHealth Technology GeneSeque AS provides single-molecule DNA-sequencing technology. It develops MagSeq, a break-through technology for single-molecule sequencing. The company was founded on February 12, 2008 and is headquartered in Trondheim, Norway. | Health Technology |
SeaFarm Solutions AS
SeaFarm Solutions AS Agricultural Commodities/MillingProcess Industries Seafarm Solutions AS designs, produces, and sells goods and services to the fishing industry. It manufactures machines and equipment for the fish farmers. The company was founded by Claus Mikael Søberg and Morten Aga on August 10, 2000 and is headquartered in Vaksdal, Norway. | Process Industries |
Caerus Capital AS
 Caerus Capital AS Pharmaceuticals: MajorHealth Technology Caerus Capital AS develops a process to produce heparin from marine raw materials. It focuses on developing novel anticoagulant agents based on biomass from the fish farming industry. The firm's technological platform is based on patented processes for extraction and purification of heparin using marine species-specifically salmon intestines-as raw material. The company was founded by Ragnar Flengsrud on December 4, 2001 and is headquartered in Hovik, Norway. | Health Technology |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Health Technology |
Christian Michelsen Research AS
 Christian Michelsen Research AS Miscellaneous Commercial ServicesCommercial Services Christian Michelsen Research AS provides research services for the development of prototypes and commercialization of research results. The company is based in Bergen, Norway. Christian Michelsen Research was acquired by Schlumberger Information Solutions on January 30, 2002. | Commercial Services |
Sarsia Innovation AS
 Sarsia Innovation AS Investment ManagersFinance Sarsia Innovation AS invests in companies located in the northern part of Norway. Selected companies are from various sectors but they all are developing new concepts in their field. The fund is currently closed for new investments. | Finance |
Med Storm Innovation AS
Med Storm Innovation AS Medical DistributorsDistribution Services Med Storm Innovation AS develops bio sensor systems. It develops medical software solutions for analyzing skin conductance or emotional sweating for monitoring and detecting stress/pain and awakening on patients. The company was founded by Hanne Storm on December 22, 1998 and is headquartered in Oslo, Norway. | Distribution Services |
Serca Pharmaceuticals AS
Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Serca Pharmaceuticals AS develops, markets, and sells drug treatment products, medicinal products, and equipment for injuries. The company was founded on October 8, 2018 and is headquartered in Lysaker, Norway. | Health Technology |
| Prophylix Holding AS | |
| Caedo Oncology AS | |
| Mitosis AS | |
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
